Total Synthesis of Tiacumicin B: Implementing H-bond-Directed Acceptor Delivery for Highly Selective beta-Glycosylations

20 December 2019, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

We report a total synthesis of tiacumicin B, one of the most structurally complex natural antibiotic macrolides. Endowed with remarkable biological properties, it is used to treat very severe intestinal infections. The strategy is in part based on our experience of the synthesis of the tiacumicin B aglycone, and on the decisive implementation of an H-bond-mediated Aglycone Delivery (HAD) using sulfoxides as anomeric leaving-groups. This new HAD variant permitted highly beta-selective rhamnosylation and noviosylation. To increase the convergence, the rhamnosylated C1-C3 fragment thus obtained was anchored to the C4-C19 aglycone fragment by adapting the reliable Suzuki-Miyaura cross-coupling conditions used for the aglycone synthesis. The ring-size selective macrolactonization provided a compound engaged directly in the noviolysation step with a virtually total beta-selectivity. The final and efficient removal of all the protective groups (PGs) provided synthetic tiacumicin B.

Keywords

antibiotics
natural products
total synthesis
catalysis
enantioselective synthesis
glycosylation

Supplementary materials

Title
Description
Actions
Title
Full Binder
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.